OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-16.34%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$242M
AUM Growth
+$242M
Cap. Flow
+$7.91M
Cap. Flow %
3.27%
Top 10 Hldgs %
92.28%
Holding
16
New
2
Increased
1
Reduced
3
Closed
–

Top Buys

1
ARQT icon
Arcutis Biotherapeutics
ARQT
$25.2M
2
BEAM icon
Beam Therapeutics
BEAM
$5.45M
3
CDTX icon
Cidara Therapeutics
CDTX
$912K

Top Sells

1
GOSS icon
Gossamer Bio
GOSS
$18.7M
2
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
$4.83M
3
EPIX icon
ESSA Pharma
EPIX
$80K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REPL icon
1
Replimune Group
REPL
$455M
$52.8M 21.86%
5,323,455
– –
MORF
2
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$43.6M 18.04%
2,969,582
– –
GOSS icon
3
Gossamer Bio
GOSS
$598M
$43.4M 17.96%
4,275,726
-1,843,619
-30% -$18.7M
ARQT icon
4
Arcutis Biotherapeutics
ARQT
$1.87B
$25.2M 10.42%
+844,680
New +$25.2M
TBIO
5
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$24.3M 10.06%
2,437,603
– –
IMUX icon
6
Immunic
IMUX
$83.2M
$8.3M 3.43%
1,371,494
– –
PRTK
7
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$8.19M 3.39%
2,600,410
– –
EPIX icon
8
ESSA Pharma
EPIX
$11.1M
$6.76M 2.8%
1,689,848
-20,000
-1% -$80K
BEAM icon
9
Beam Therapeutics
BEAM
$1.66B
$5.45M 2.26%
+302,821
New +$5.45M
CDTX icon
10
Cidara Therapeutics
CDTX
$1.69B
$4.98M 2.06%
2,008,150
+367,636
+22% +$912K
FGEN icon
11
FibroGen
FGEN
$46.3M
$4.54M 1.88%
130,646
– –
TRVI icon
12
Trevi Therapeutics
TRVI
$891M
$4.16M 1.72%
1,263,408
– –
PRVL
13
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$3.33M 1.38%
272,807
-396,100
-59% -$4.83M
JNCE
14
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.52M 1.04%
529,965
– –
OBSV
15
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.41M 1%
999,364
– –
PVLA
16
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$1.71M 0.71%
750,741
– –